Mind + Muscle

technical minds + legal muscle


dig deep

Another Layer of Complexity

  • 06.20.14
  • Gaby L. Longsworth Ph.D., Marsha R. Gillentine Ph.D., and Eric K. Steffe
  • The Patent Lawyer

Directors Gaby L. Longsworth, Ph.D., Marsha R. Gillentine, Ph.D., and Eric K. Steffe, outline the consequences of the recent Federal Circuit ruling in Gilead Sciences v. Natco Pharma Ltd. Published in The Patent Lawyer, this report details the scope of obviousness-type double patenting (ODP). The authors note that "The ruling in Gilead could have major ramifications for the term of a significant number of existing patents. This is particularly true in the biotech and pharma industries where prosecution of multiple applications in the same family and related families is common." 

To read the full article, please download the attached PDF.  

Related People

Related Services

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.